Inactive Instrument

Curetis N.V. Stock price

Equities

Advanced Medical Equipment & Technology

Dynamic Chart
Managers TitleAgeSince
Founder - 07-07-31
Founder 55 07-07-31
Corporate Officer/Principal - -
More insiders
Curetis specializes in the development and marketing of molecular diagnostic systems for hospitals and laboratories. The products are devoted to detecting severe infectious diseases as well as resistance to anti-biotics in hospitalized patients. The diagnostic solutions (Unyvero Solution) enable rapid multi-parameter pathogen and antibiotic resistance detection in only a few hours, a process that today can take up to days or even weeks with other techniques. Syndromic tests for diagnosing lower respiratory tract infections /pneumonia as well as implant and tissue infections are commercially available.
More about the company
  1. Stock
  2. Equities
  3. Stock Curetis N.V. - Euronext Amsterdam